Intrinsic Value

The intrinsic value of Oxford Biodynamics PLC (OXBOF) under the Base Case is 0.001 USD per share. Compared with the current market price of 0.003 USD, the stock appears Overvalued by 76% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

OXBOF Intrinsic Value
$0.001
Overvaluation 76%
Intrinsic Value
Price $0.003
Alert me when OXBOF is below its intrinsic value
Today $0.001 · 80.8% below the current price

OXBOF is valued in line with its history. A premium of this size has been typical over the past 5 years.

Alternatives to OXBOF

Fundamental Analysis

What Oxford Biodynamics Does

Life Sciences Tools & Services Health Care

Oxford Biodynamics is a biotechnology company that develops blood-based tests using its EpiSwitch platform, which looks at how DNA is folded in the cell to find disease signals. The company’s core work is to discover and validate biomarkers that can help identify cancer and other serious diseases earlier or more accurately than standard tests.

Headquarters
United Kingdom UK
Employees
41
IPO date
Dec 6, 2016
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue OXBOF Research

Decided on Oxford Biodynamics? Get an email when OXBOF reaches the price you’d buy at. Free with an account.

Other Oxford Biodynamics listings

What is the Intrinsic Value of one OXBOF stock?

The intrinsic value for Oxford Biodynamics PLC (OXBOF) under the Base Case is 0.001 USD.

Is OXBOF stock undervalued or overvalued?

Compared with the current market price of 0.003 USD, the stock appears Overvalued by 76% .

How reliable are our estimates? See how past valuations played out
Back to Top